Please assess the completion status of the following clinical trial:

Trial Title: Treatment Advocacy Intervention for HIV-Positive African Americans

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age or older;~* self-identify as African American or Black~* client of APLA~* they are on ART and missed at least 1 dose in the past month~* they have a currently detectable or unknown HIV viral load (or have not had a viral load test within the last six months).~Exclusion Criteria:~* received treatment advocacy in last 6 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Wait-list control (Type: NO_INTERVENTION): Participants in the wait-list control group will not receive the intervention until after the 6-month follow-up assessment.
- treatment advocacy (Type: EXPERIMENTAL): Treatment advocacy is a 24-week intervention with booster sessions, including a 4-week intensive intervention followed by a 20-week maintenance period. In the first 4 weeks, all participants receive 4 individual weekly 60-minute sessions and 1 group HIV education session. In the next 20 weeks, all participants receive booster sessions in weeks 12 and 20, and a counselor check-in phone call in week 8 regarding need for new referrals and adherence barriers. Participants who have not demonstrated good adherence (≥90%) during the prior 2 weeks receive ≤4 additional booster sessions at weeks 14, 16, 22, and 24. Clients receive additional linkage with AIDS Project Los Angeles' (APLA) social service programs, as necessary.

Based on this trial design, predict the completion outcome and termination type (if applicable).